Clinical Trials on Multiple Sclerosis, Relapsing-Remitting
Total 3098 results
-
Genentech, Inc.Roche Pharma AGCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada, Belgium, Spain, France, Switzerland, Ukraine, Mexico, Germany, Bulgaria, United Kingdom, Romania, Czechia, Italy, Russian Federation, Serbia, Slovakia, Denmark
-
BiogenCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingGermany
-
Rennes University HospitalInstitut National de Recherche en Informatique et en Automatique; Association... and other collaboratorsCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
doaa mokhtar mahmoudCompletedMultiple Sclerosis, Relapsing-RemittingEgypt
-
University Hospital, CaenBiogenCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
Marquette UniversityUniversity of Wisconsin, MilwaukeeCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Northwestern UniversityTerminatedMultiple Sclerosis, Relapsing-RemittingUnited States
-
GeNeuro SAWorldwide Clinical Trials; Institut de Recherches Internationales Servier; Les...CompletedMultiple Sclerosis, Relapsing-RemittingPoland, Ukraine, Germany, Spain, Bulgaria, Serbia, Russian Federation, Hungary, Italy, Croatia, Czechia, Estonia
-
Genentech, Inc.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
Merck KGaA, Darmstadt, GermanyTerminatedMultiple Sclerosis, Relapsing-RemittingItaly
-
University of CalgaryAlberta Innovates Health SolutionsCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
Fondation Ophtalmologique Adolphe de RothschildTerminatedMonitoring of Patients Followed for a Multiple Sclerosis and Treated by Dimethyl-fumarate (SURV-SEP)Multiple Sclerosis, Relapsing-RemittingFrance
-
Gazi UniversityCompletedMultiple Sclerosis, Relapsing-RemittingTurkey
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingSpain
-
Imcyse SATerminatedMultiple Sclerosis, Relapsing-RemittingBelgium
-
Genzyme, a Sanofi CompanyBayerCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands, Spain, Germany, Israel, United Kingdom, Canada, Australia, United States, Italy, Argentina, Croatia, Russian Federation, Poland, Czechia, Belgium, France, Brazil, Austria, Denmark, Mexico, Serbia, Sweden, Ukraine
-
BiogenElan PharmaceuticalsCompleted
-
Universitätsklinikum Hamburg-EppendorfCompletedMultiple Sclerosis, Relapsing-Remitting
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Canada
-
University of AarhusAarhus University Hospital; BiogenCompletedMultiple Sclerosis (Relapsing Remitting)Denmark
-
Merck KGaA, Darmstadt, GermanyMerck A.E., GreeceCompleted
-
Merck KGaA, Darmstadt, GermanyMerck Serono S.A., GenevaCompletedMultiple Sclerosis, Relapsing-RemittingNetherlands
-
Rennes University HospitalUnknownMultiple Sclerosis, Relapsing-RemittingFrance
-
BayerCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
McGill UniversityCompletedMultiple Sclerosis, Relapsing-RemittingCanada
-
BayerCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedMultiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveFrance
-
Friedemann PaulRoche Pharma AGActive, not recruitingMultiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary ProgressiveGermany
-
Kessler FoundationSt. Barnabas Medical CenterRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Massachusetts General HospitalCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
National Institute of Allergy and Infectious Diseases...Autoimmunity Centers of ExcellenceTerminatedMultiple Sclerosis (MS) - Relapsing-remittingUnited States
-
Nottingham University Hospitals NHS TrustNot yet recruitingMultiple Sclerosis | Covid19 | Relapsing Remitting Multiple Sclerosis
-
Universität MünsterRecruitingMultiple Sclerosis, Relapsing-RemittingGermany
-
Hasselt UniversityRecruitingMultiple Sclerosis, Relapsing-RemittingBelgium
-
Bristol-Myers SquibbRecruiting
-
BiogenRecruitingMultiple Sclerosis, Relapsing-RemittingGermany
-
Amsterdam UMC, location VUmcRecruitingMultiple Sclerosis, Relapsing-RemittingNetherlands
-
Immunic AGRecruitingMultiple Sclerosis, Relapsing-RemittingTurkey, United States, India, United Kingdom, Bosnia and Herzegovina, Estonia, Poland, Romania, Serbia, Ukraine, Armenia
-
University of Alabama at BirminghamRecruitingMultiple Sclerosis, Relapsing-RemittingUnited States
-
Berkovich, Regina MD, PhD Inc.Biogen; Cedars-Sinai Medical CenterRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Riley Bove, MDRecruitingMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingCanada, United States
-
Rennes University HospitalActive, not recruiting
-
CelgeneCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingUnited States, Germany
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Spain, Canada, Australia, Germany, Italy, United Kingdom, Belgium, Netherlands, France, Israel
-
Mapi Pharma Ltd.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Estonia, Georgia, Israel, Moldova, Republic of, Russian Federation, Ukraine
-
Uppsala UniversityKarolinska University Hospital; Sahlgrenska University Hospital, Sweden; University... and other collaboratorsCompletedMultiple Sclerosis | Multiple Sclerosis, Relapsing-RemittingSweden
-
BiogenCompletedMultiple Sclerosis, Relapsing-RemittingFrance
-
Hoffmann-La RocheCompletedMultiple Sclerosis, Relapsing-RemittingBelgium, United Kingdom, Australia, Netherlands, Ireland, Norway, Turkey, Estonia, Denmark, Germany, Italy, Spain, Switzerland, France, Finland, Sweden, Czechia
-
University of California, San FranciscoCompletedMultiple Sclerosis, Relapsing-RemittingUnited States